Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Selective Glucocorticoid Receptor Antagonism in Alcohol Use Disorder: A Human Laboratory Study

NCT06712602 is registered in ClinicalTrials.gov with Pop Test Oncology LLC as lead sponsor.

NCT NCT06712602
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06712602 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Selective Glucocorticoid Receptor Antagonism in Alcohol Use Disorder: A Human Laboratory Study
Lead sponsor
Pop Test Oncology LLC
Phase
Phase 1
Overall status
Recruiting
Start date
February 1, 2025
Completion date
July 31, 2028
Enrollment
34 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol use disorder